{"id":"https://openalex.org/W2108949223","doi":null,"title":"A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.","display_name":"A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2108949223","mag":"2108949223","pmid":"https://pubmed.ncbi.nlm.nih.gov/11205919"},"language":"en","primary_location":{"id":"pmid:11205919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11205919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081453445","display_name":"Francisco A. Bracho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F Bracho","raw_affiliation_strings":["Lombardi Cancer Center, Georgetown University Hospital, Washington, DC 20007, USA","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Cancer Center, Georgetown University Hospital, Washington, DC 20007, USA","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090325707","display_name":"Mark Krailo","orcid":"https://orcid.org/0000-0002-7608-0698","observed_orcids":["https://orcid.org/0000-0002-7608-0698"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M D Krailo","raw_affiliation_strings":["University of Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115593698","display_name":"Violet Shen","orcid":"https://orcid.org/0000-0002-0737-5193","observed_orcids":["https://orcid.org/0000-0002-0737-5193"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V Shen","raw_affiliation_strings":["University of California, at Irvine#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, at Irvine#TAB#","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032957928","display_name":"Sharon Bergeron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Bergeron","raw_affiliation_strings":["University of Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009922646","display_name":"Virginia D. Davenport","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V Davenport","raw_affiliation_strings":["Columbia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044829454","display_name":"Wen Liu\u2010Mares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W Liu-Mares","raw_affiliation_strings":["University of Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058268746","display_name":"Bruce R. Blazar","orcid":"https://orcid.org/0000-0002-9608-9841","observed_orcids":["https://orcid.org/0000-0002-9608-9841"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B R Blazar","raw_affiliation_strings":["University of Minnesota Twin Cities"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota Twin Cities","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045561472","display_name":"Angela Panoskaltsis\u2010Mortari","orcid":"https://orcid.org/0000-0003-1802-1785","observed_orcids":["https://orcid.org/0000-0003-1802-1785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Panoskaltsis-Mortari","raw_affiliation_strings":["Pediatric Blood & Marrow Transplant & Cellular Therapy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Blood & Marrow Transplant & Cellular Therapy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075246827","display_name":"Carmella van de Ven","orcid":"https://orcid.org/0000-0001-7919-1089","observed_orcids":["https://orcid.org/0000-0001-7919-1089"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C van de Ven","raw_affiliation_strings":["Columbia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034694248","display_name":"Rita Secola","orcid":"https://orcid.org/0000-0002-0573-7023","observed_orcids":["https://orcid.org/0000-0002-0573-7023"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Secola","raw_affiliation_strings":["University of Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M M Ames","raw_affiliation_strings":["Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J M Reid","raw_affiliation_strings":["Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019914745","display_name":"Gregory H. Reaman","orcid":"https://orcid.org/0000-0002-6698-4503","observed_orcids":["https://orcid.org/0000-0002-6698-4503"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G H Reaman","raw_affiliation_strings":["Children\u00bfs National Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u00bfs National Medical Center","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001697191","display_name":"Mitchell Stuart Cairo","orcid":"https://orcid.org/0000-0002-2075-434X","observed_orcids":["https://orcid.org/0000-0002-2075-434X"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M S Cairo","raw_affiliation_strings":["Columbia University","University of Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"University of Southern California","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8829,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.74132098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"1","first_page":"58","last_page":"67"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9869999885559082},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9679999947547913},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9079999923706055},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/pediatric-solid-tumors","display_name":"pediatric solid tumors","score":0.7720000147819519},{"id":"https://openalex.org/keywords/hematopoietic-recovery","display_name":"hematopoietic recovery","score":0.847000002861023},{"id":"https://openalex.org/keywords/myelosuppressive-chemotherapy","display_name":"myelosuppressive chemotherapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/peripheral-blood-progenitor-cells","display_name":"peripheral blood progenitor cells","score":0.8140000104904175},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7269999980926514},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.8920000195503235},{"id":"https://openalex.org/keywords/interleukin-3-receptor","display_name":"interleukin-3 receptor","score":0.6100000143051147},{"id":"https://openalex.org/keywords/g-csf-receptor","display_name":"G-CSF receptor","score":0.6610000133514404},{"id":"https://openalex.org/keywords/il-6-receptor","display_name":"IL-6 receptor","score":0.7580000162124634},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6959999799728394},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7010788917541504},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.6487547755241394},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6084702014923096},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5709916353225708},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5597279071807861},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.507550835609436},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5011773109436035},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4883686900138855},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47873780131340027},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46498459577560425},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3717772364616394},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3216555714607239},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11205919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11205919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2108949223","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11205919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G4229970524","display_name":"Mayo Cancer Genetic Epidemiology Training Program","funder_award_id":"R25CA092049","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W69440101","https://openalex.org/W336773932","https://openalex.org/W1577568147","https://openalex.org/W1602618889","https://openalex.org/W1720359783","https://openalex.org/W1825344511","https://openalex.org/W1830581460","https://openalex.org/W1970854796","https://openalex.org/W1973625640","https://openalex.org/W2002076761","https://openalex.org/W2017819098","https://openalex.org/W2024606960","https://openalex.org/W2026773500","https://openalex.org/W2027579739","https://openalex.org/W2062178434","https://openalex.org/W2071285562","https://openalex.org/W2083875741","https://openalex.org/W2091235167","https://openalex.org/W2106786890","https://openalex.org/W2121493622","https://openalex.org/W2137392293","https://openalex.org/W2138040687","https://openalex.org/W2265678353","https://openalex.org/W2265969331","https://openalex.org/W2287680939","https://openalex.org/W2298584763","https://openalex.org/W2337465180","https://openalex.org/W2340195488","https://openalex.org/W2398650121","https://openalex.org/W2403122640","https://openalex.org/W2412706078","https://openalex.org/W2419138996","https://openalex.org/W2463276924","https://openalex.org/W2472329363","https://openalex.org/W3111763978"],"related_works":["https://openalex.org/W2011539491","https://openalex.org/W2171663536","https://openalex.org/W2396186962","https://openalex.org/W4298194308","https://openalex.org/W2014417747","https://openalex.org/W1986979881","https://openalex.org/W2328023492","https://openalex.org/W2028681561","https://openalex.org/W2106926219","https://openalex.org/W2319761944"],"abstract_inverted_index":{"A":[0],"Phase":[1],"I":[2],"trial":[3],"was":[4,169,179,209],"conducted":[5],"to":[6,194,223],"determine":[7],"the":[8,16,157,188,191,236],"safety,":[9],"biological":[10],"activity,":[11],"and":[12,22,60,74,88,104,143,202,213,226,248,264],"hematopoietic":[13,85],"recovery":[14],"by":[15,68],"combination":[17],"of":[18,35,109,130,137,145,162,164,175,239,261,276],"interleukin":[19],"6":[20],"(IL-6)":[21],"granulocyte-colony":[23],"stimulating":[24],"factor":[25],"(G-CSF)":[26],"after":[27,280],"myelosuppressive":[28],"chemotherapy":[29,281],"in":[30,128,245,253,268,278,291],"children.":[31],"Patients":[32],"<22":[33],"years":[34],"age":[36],"at":[37,107,133,140,148,211],"diagnosis":[38],"with":[39,271],"either":[40],"recurrent":[41],"or":[42,78,118,199,205],"refractory":[43],"solid":[44],"tumors":[45],"received":[46,105],"ifosfamide":[47],"1,800":[48],"mg/m2/day":[49,63],"x":[50,57,64],"5":[51,65],"days,":[52,59,66,215],"carboplatin":[53],"400":[54],"mg/m2/":[55],"day":[56],"2":[58],"etoposide":[61],"100":[62],"followed":[67],"daily":[69],"s.c.":[70],"G-CSF":[71,227],"(5":[72],"microg/kg/day)":[73,178],"IL-6":[75,106,176,256,277,285],"(2.5,":[76],"3.75,":[77],"5.0":[79,119,134],"microg/kg/day).":[80],"Pharmacokinetic,":[81],"proinflammatory":[82],"mediator":[83],"levels,":[84],"colony":[86],"assays,":[87],"cytokine":[89],"receptor":[90],"expression":[91],"studies":[92],"were":[93,100,243,251],"performed":[94],"during":[95],"course":[96],"one.":[97],"Nineteen":[98],"patients":[99,132,139,147],"evaluable":[101],"for":[102],"toxicity":[103,126,263],"doses":[108],"2.5":[110,149],"(n":[111,115,120],"=":[112,116,121,200,206],"8),":[113],"3.75":[114,141],"5),":[117],"6)":[122],"microg/kg/day.":[123,150],"Dose-limiting":[124],"constitutional":[125,262],"occurred":[127],"two":[129,136,144],"six":[131],"microg/kg/day,":[135,142],"five":[138],"eight":[146],"The":[151,172],"maximum":[152,173],"tolerated":[153],"dose":[154,159,238],"(MTD)":[155],"exceeded":[156],"lowest":[158],"tested.":[160],"Because":[161],"lack":[163],"drug":[165],"availability,":[166],"an":[167],"MTD":[168,267],"not":[170],"established.":[171],"concentration":[174],"(2.5":[177],"0.799":[180],"+/-":[181,185],"1.055":[182],"ng/ml":[183],"(mean":[184],"SD).":[186],"During":[187],"first":[189,237],"course,":[190],"median":[192],"time":[193],"absolute":[195],"neutrophil":[196],"count":[197],">":[198,204],"1,000/mm3":[201],"platelets":[203],"100,000":[207],"mm3":[208],"estimated":[210],"19":[212],"23":[214],"respectively.":[216],"Peripheral":[217],"blood":[218],"progenitor":[219],"cells":[220],"expressing":[221],"receptors":[222],"IL-3,":[224],"IL-6,":[225,240],"increased":[228],"significantly":[229],"over":[230],"baseline":[231],"(P":[232],"<":[233],"0.05).":[234],"After":[235],"IFN-gamma":[241],"levels":[242,250],"abnormal":[244,252],"13":[246],"patients,":[247],"IL-1beta":[249],"10":[254],"patients.":[255],"has":[257],"a":[258,265],"high":[259],"incidence":[260],"lower":[266],"children":[269,279,292],"compared":[270],"adults.":[272],"In":[273],"vivo":[274,295],"use":[275],"remains":[282],"limited.":[283],"However,":[284],"may":[286],"be":[287],"more":[288],"optimally":[289],"investigated":[290],"under":[293],"ex":[294],"conditions.":[296]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}